Fresh Rounds

Crosslink Therapeutics Inc. funding

Crosslink Therapeutics Inc., a pharmaceuticals company based in Boston, MA (founded 2021), filed a Form D with the SEC on October 20, 2026 and reported $5.5M raised.

Amount raised$5.5M
Offering size$5.5M
Filed with the SECOctober 20, 2026
First saleOctober 8, 2026
IndustryPharmaceuticals
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationBoston, MA
Founded2021
Entity typeCorporation
Investors so far8
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Massachusetts